Hypercholesterolemia and Hyperlipidaemia
Hyperlipidemia has no symptoms, so the only way to detect it is to have your doctor perform a blood test called a lipid profile or a lipid panel. Lifestyle changes are the important aspects for managing hyperlipidemia. Elevated levels of cholesterol in the blood may be an outcome of obesity, unhealthy diet, inherited or the presence of other diseases such as type 2 diabetes. These changes alone may be enough to reduce the risk of complications like heart disease and stroke. It causes LDL (bad) cholesterol level to be very high. The condition begins at birth and can cause heart attacks at an early age.
- Familial hypercholesterolemia
- Alzheimer’s disease
- Hemorrhagic stroke
- Cholestatic liver disease
- Apoprotein disorders
- Peripheral arterial disease
- Diagnosis, treatments and medications
Related Conference of Hypercholesterolemia and Hyperlipidaemia
November 23-24, 2026
35th International Conference on Clinical Diabetes, Diabetic Medication & Treatment
Amsterdam, Netherlands
March 29-30, 2027
25th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders
Paris, France
April 27-28, 2027
38th International Congress on Prevention of Diabetes and Complications
Paris, France
July 26-27, 2027
25th Global Conference on Diabetes, Endocrinology and Primary Healthcare
Paris, France
Hypercholesterolemia and Hyperlipidaemia Conference Speakers
Recommended Sessions
- Cholesterol Metabolism and Diabetes
- Cholesterol, High Blood Pressure and Diabetes
- Diabetes and Obesity
- Diabetes Complications
- Diabetes Types and Symptoms
- Diabetic Education and Healthcare Professionals
- Diabetic Nutrition & Physical Fitness
- Endocrinology
- General Pediatrics
- Genetic Basis of Diabetes
- Gestational Diabetes
- Hypercholesterolemia and Hyperlipidaemia
- Medical Devices and Technologies used in Diabetes Treatment
- Metabolic Syndrome
- Pediatric Allergy
- Pediatric and Adolescent Diabetes
- Pediatric Endocrinology
- Pediatric Infectious diseases
- Stem Cell Therapy and Nanotechnology in Diabetes
Related Journals
Are you interested in
- Adrenal and Pituitary Disorders - Diabetes Conference 2027 (Netherlands)
- Adrenal Disorders - Diabetes Meet 2027 (France)
- Advances in Diabetes Research - Diabetes Conference 2027 (Netherlands)
- Advances in Diabetes Research & Pathophysiology - Diabetes-2027 (UK)
- Advances in Diabetes Treatment - Diabetes Meet 2027 (France)
- AI Meets Endocrinology: From Algorithms to Clinical Decisions - Endocrinology Conference 2027 (France)
- Artificial Intelligence and Data Science - Diabetes Medicare 2026 (Netherlands)
- Artificial Intelligence and Smart Technologies in Endocrinology and Diabetes - ENDOCRINE CONGRESS 2026 (Italy)
- Artificial Intelligence in Diabetes Care - Diabetes Conference 2027 (Netherlands)
- Artificial Intelligence, Digital Health & Diabetes - Diabetes-2027 (UK)
- Beta Cells under the Microscope: Repair, Replace, Reprogram - Endocrinology Conference 2027 (France)
- Biomedical Innovation and Translational Medicine - Diabetes Medicare 2026 (Netherlands)
- Blockchain Technology and Digital Transformation - Diabetes Medicare 2026 (Netherlands)
- Bone and Mineral Metabolism - ENDOCRINE CONGRESS 2026 (Italy)
- Bone and Mineral Metabolism - Diabetes Meet 2027 (France)
- Bone Health - Euro Endocrinology 2027 (UK)
- Bone Health and Mineral Metabolism - Diabetes Conference 2027 (Netherlands)
- Cardiology, Cardiovascular Health and Preventive Cardiology - Diabetes Medicare 2026 (Netherlands)
- Cardiometabolic Health - Diabetes Conference 2027 (Netherlands)
- Childhood Obesity - Euro Endocrinology 2027 (UK)
- Circadian Rhythms - Euro Endocrinology 2027 (UK)
- Clinical Diabetes, Diabetic Medication and Treatment Strategies - Diabetes Medicare 2026 (Netherlands)
- Clinical Endocrinology - Diabetes Conference 2027 (Netherlands)
- Cloud Computing and Distributed Systems - Diabetes Medicare 2026 (Netherlands)
- Current Research and Innovations in Endocrinology and Diabetes - ENDOCRINE CONGRESS 2026 (Italy)
- Cybersecurity and Information Assurance - Diabetes Medicare 2026 (Netherlands)
- Diabetes - Euro Endocrinology 2027 (UK)
- Diabetes 2030: The Future beyond Insulin - Endocrinology Conference 2027 (France)
- Diabetes and Cardiovascular Health - Diabetes Meet 2027 (France)
- Diabetes Complications - Diabetes Conference 2027 (Netherlands)
- Diabetes Complications - ENDOCRINE CONGRESS 2026 (Italy)
- Diabetes Complications - Diabetes Meet 2027 (France)
- Diabetes Complications & Comorbidity Management - Diabetes-2027 (UK)
- Diabetes Education & Patient-Centered Care - Diabetes-2027 (UK)
- Diabetes Education and Patient Engagement - Diabetes Conference 2027 (Netherlands)
- Diabetes in Ageing - Diabetes Meet 2027 (France)
- Diabetes Management Innovations - Euro Endocrinology 2027 (UK)
- Diabetes Mellitus - Diabetes Meet 2027 (France)
- Diabetes Mellitus and Glycaemic Control - ENDOCRINE CONGRESS 2026 (Italy)
- Diabetes Nursing and Patient Care - Diabetes Meet 2027 (France)
- Diabetes Pharmacology and Therapeutics - Diabetes Conference 2027 (Netherlands)
- Diabetes Prevention - Euro Endocrinology 2027 (UK)
- Diabetes Prevention & Early Detection - Diabetes-2027 (UK)
- Diabetes Public Health & Global Health Strategies - Diabetes-2027 (UK)
- Diabetes Technology and Digital Health - Diabetes Conference 2027 (Netherlands)
- Diabetes Technology and Digital Health - Diabetes Meet 2027 (France)
- Diabetes Technology, Wearables & Remote Patient Monitoring - Diabetes-2027 (UK)
- Diabetes Therapeutics & Pharmacological Innovations - Diabetes-2027 (UK)
- Diabetes Treatments - Euro Endocrinology 2027 (UK)
- Diabetes, Obesity & Metabolic Disorders - Diabetes-2027 (UK)
- Diabetic Kidney Disease - Diabetes Meet 2027 (France)
- Diabetic Neuropathy and Retinopathy - Diabetes Meet 2027 (France)
- Diabetic Nutrition and Diet - Euro Endocrinology 2027 (UK)
- Digital Health - Euro Endocrinology 2027 (UK)
- Digital Health and Tele-Endocrinology - ENDOCRINE CONGRESS 2026 (Italy)
- Emerging Innovations in Endocrinology - Diabetes Conference 2027 (Netherlands)
- Emerging Technologies and Digital Innovation - Diabetes Medicare 2026 (Netherlands)
- Emerging Therapeutics and Drug Development - ENDOCRINE CONGRESS 2026 (Italy)
- Endocrine Cancer - Euro Endocrinology 2027 (UK)
- Endocrine Disorders - Euro Endocrinology 2027 (UK)
- Endocrine Disorders in Men - ENDOCRINE CONGRESS 2026 (Italy)
- Endocrine Disorders in Women - ENDOCRINE CONGRESS 2026 (Italy)
- Endocrine Disruptors & Planetary Health - Endocrinology Conference 2027 (France)
- Endocrine Genetics and Genomic Medicine - Diabetes Conference 2027 (Netherlands)
- Endocrine Genetics and Molecular Biology - ENDOCRINE CONGRESS 2026 (Italy)
- Endocrine Nursing and Patient Care - ENDOCRINE CONGRESS 2026 (Italy)
- Endocrine Oncology - Diabetes Conference 2027 (Netherlands)
- Endocrine Oncology - ENDOCRINE CONGRESS 2026 (Italy)
- Endocrine Oncology - Diabetes Meet 2027 (France)
- Endocrinology - ENDOCRINE CONGRESS 2026 (Italy)
- Endocrinology - Diabetes Meet 2027 (France)
- Endocrinology - Euro Endocrinology 2027 (UK)
- Exercise, Lifestyle and Diabetes Prevention - Diabetes Conference 2027 (Netherlands)
- Future Perspectives in Diabetes and Endocrine Research - Diabetes Conference 2027 (Netherlands)
- Future Trends & Innovations in Diabetes Care - Diabetes-2027 (UK)
- Future Trends and Challenges in Endocrinology - ENDOCRINE CONGRESS 2026 (Italy)
- Geriatric Medicine, Aging Science and Elderly Care - Diabetes Medicare 2026 (Netherlands)
- Gestational Diabetes - Euro Endocrinology 2027 (UK)
- Gestational Diabetes and Women's Health - Diabetes Conference 2027 (Netherlands)
- Health Informatics, AI in Healthcare and Digital Transformation - Diabetes Medicare 2026 (Netherlands)
- Hormonal Replacement Therapy - Euro Endocrinology 2027 (UK)
- Insulin Delivery & Glucose Monitoring Technologies - Diabetes-2027 (UK)
- Insulin Resistance - Euro Endocrinology 2027 (UK)
- Internet of Things (IoT) and Smart Systems - Diabetes Medicare 2026 (Netherlands)
- Lipid Disorders and Dyslipidemia - Diabetes Meet 2027 (France)
- Male Endocrinology - Diabetes Meet 2027 (France)
- MASLD & Metabolic Liver Disease: The Liver–Endocrine Connection - Endocrinology Conference 2027 (France)
- Medical Ethics, Healthcare Policy and Regulatory Affairs - Diabetes Medicare 2026 (Netherlands)
- Medical Imaging, Diagnostics and Digital Health Technologies - Diabetes Medicare 2026 (Netherlands)
- Medical Robotics, Rehabilitation Engineering and Assistive Technologies - Diabetes Medicare 2026 (Netherlands)
- Menstrual Irregularities - Euro Endocrinology 2027 (UK)
- Mental Health, Behavioral Sciences and Wellbeing - Diabetes Medicare 2026 (Netherlands)
- Neuroendocrinology - Euro Endocrinology 2027 (UK)
- Next-Gen Endocrine Therapeutics: From Molecules to Medicines - Endocrinology Conference 2027 (France)
- Nursing Science, Patient Care and Clinical Practice - Diabetes Medicare 2026 (Netherlands)
- Nutrition and Lifestyle Medicine - ENDOCRINE CONGRESS 2026 (Italy)
- Nutrition and Lifestyle Medicine - Diabetes Meet 2027 (France)
- Nutrition and Medical Nutrition Therapy - Diabetes Conference 2027 (Netherlands)
- Nutrition, Lifestyle & Exercise in Diabetes - Diabetes-2027 (UK)
- Obesity - Euro Endocrinology 2027 (UK)
- Obesity and Metabolic Syndrome - ENDOCRINE CONGRESS 2026 (Italy)
- Obesity and Metabolic Syndrome - Diabetes Meet 2027 (France)
- Obesity and Weight Management - Diabetes Conference 2027 (Netherlands)
- Obesity Unfiltered: Biology, Brain, Behavior & Breakthrough Therapies - Endocrinology Conference 2027 (France)
- Oncology, Cancer Research and Precision Oncology - Diabetes Medicare 2026 (Netherlands)
- Paediatric Endocrinology - ENDOCRINE CONGRESS 2026 (Italy)
- Paediatric Endocrinology - Diabetes Meet 2027 (France)
- Paediatric, Adolescent & Gestational Diabetes - Diabetes-2027 (UK)
- Parathyroid Disorders - Diabetes Meet 2027 (France)
- Pediatric Diabetes and Endocrine Disorders - Diabetes Conference 2027 (Netherlands)
- Pediatric Endocrinology - Euro Endocrinology 2027 (UK)
- Pharmacology, Drug Development and Clinical Therapeutics - Diabetes Medicare 2026 (Netherlands)
- Pituitary and Hypothalamic Disorders - Diabetes Meet 2027 (France)
- Precision Medicine & Personalized Diabetes Care - Diabetes-2027 (UK)
- Precision Medicine in Endocrinology - Diabetes Conference 2027 (Netherlands)
- Precision Medicine in Endocrinology - ENDOCRINE CONGRESS 2026 (Italy)
- Precision Metabolic Medicine: One Patient, One Metabolic Signature - Endocrinology Conference 2027 (France)
- Public Health and Global Diabetes Burden - Diabetes Conference 2027 (Netherlands)
- Public Health and Global Endocrine Challenges - ENDOCRINE CONGRESS 2026 (Italy)
- Public Health, Epidemiology and Preventive Medicine - Diabetes Medicare 2026 (Netherlands)
- Regenerative Medicine and Stem Cell Therapy - Diabetes Conference 2027 (Netherlands)
- Reproductive Endocrinology and Fertility - Diabetes Conference 2027 (Netherlands)
- Reproductive Endocrinology and Women’s Health - Diabetes Meet 2027 (France)
- Sustainable Development and Green Technologies - Diabetes Medicare 2026 (Netherlands)
- The GLP-1 Revolution: Beyond Weight Loss & Glycemic Control - Endocrinology Conference 2027 (France)
- The Gut–Hormone–Brain Axis: Micro biome to Metabolism - Endocrinology Conference 2027 (France)
- Thyroid Disorders - Diabetes Conference 2027 (Netherlands)
- Thyroid Disorders - ENDOCRINE CONGRESS 2026 (Italy)
- Thyroid Disorders - Diabetes Meet 2027 (France)
- Thyroid Disorders - Euro Endocrinology 2027 (UK)
- Track 10: Glucotoxicity - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Track 11: Mitochondrial Metabolism - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Track 12: Metabolic Inflammation - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Track 13: Sarcopenia & Metabolic Health - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Track 14: Endocrine Disruptors - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Track 15: Emerging Therapies - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Track 1: Cardiometabolism - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Track 2: Insulin Resistance - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Track 3: Dyslipidemia - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Track 4: Metabolic Liver Disease (MASLD / MASH) - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Track 5: Gut Microbiota - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Track 6: Metabolomics - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Track 7: Adipokines - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Track 8: Incretins - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Track 9: Lipotoxicity - ENDOCRINE METABOLIC SYNDROME 2027 (Italy)
- Treatment for diabetes - ENDOCRINE CONGRESS 2026 (Italy)
- Treatment for Endocrinology - ENDOCRINE CONGRESS 2026 (Italy)
- Type 1 & Type 2 Diabetes - Diabetes-2027 (UK)
- Type 1 Diabetes - Diabetes Conference 2027 (Netherlands)
- Type 1 Diabetes - Euro Endocrinology 2027 (UK)
- Type 2 Diabetes - Euro Endocrinology 2027 (UK)
- Type 2 Diabetes and Metabolic Syndrome - Diabetes Conference 2027 (Netherlands)